Infectious Disease Clinics of North America volume 24, issue 2, P285-306 2010 DOI: 10.1016/j.idc.2010.01.006 View full text
|
|
Share
Sophia Koo, Francisco M. Marty, Lindsey R. Baden

Abstract: The armamentarium of biologic therapies targeting specific elements of the immune system is rapidly expanding. This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration.